Search

You searched for "impaired"

2025 results found

Stem cell transplantation and pterygium surgery

28 November 2022 | | EYE - General
Pterygium is a benign, fibrovascular overgrowth of bulbar conjunctiva extending onto the cornea and has been associated with ultraviolet (UV) light exposure. The prevalence of pterygium worldwide varies between geographical zones but has been reported to range between three and...

Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service

3 April 2023 | | EYE - General
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...
Current Eye Research journal cover image.

Detecting apoptosis in retinal cells

1 February 2022 | | EYE - Vitreo-Retinal | Apoptosis, Glaucoma, Imaging, Neurodegeneration, Retina
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...

Clinical trial investigates ‘Light Touch’ approach to wet AMD treatment

20 October 2025 | NIHR, Treatment, Retina, neovascularisation, vision
A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...

College of Optometrists publishes guidance on GLP-1 weight loss drugs and vision

1 April 2026 | treatment, optometry, public health
GLP-1 weight loss drugs and vision: what clinicians need to know The College of Optometrists has issued guidance for clinicians following the publication of a recent MHRA drug safety update which has drawn attention to a very rare risk of...

Traumatic optic neuropathy

1 October 2021 | | EYE - Orbit, EYE - Neuro-ophthalmology, EYE - General
In neuro-ophthalmology we get asked a lot about management of patients who suffered significant trauma and presented with loss of vision secondary to presumed traumatic optic neuropathy (TON). TON happens usually in the context of significant craniofacial trauma. The incidence...

Running a high-volume nurse led intravitreal service using the Sp.eye device – the Stanley Eye Unit experience

2 February 2024 | | EYE - Vitreo-Retinal
Introduction The vast majority of ophthalmology units utilise allied healthcare professionals (AHPs) to deliver intravitreal injections (IVIs). The Royal College of Ophthalmologists issued a statement 10 years ago advocating the use of non-medical practitioners performing IVIs [1]. The main benefit...

Congenital cataract

4 December 2025 | | EYE - Cataract, EYE - Paediatrics
Congenital cataract is the clouding or opacification of the lens that occurs at birth or weeks after (infantile cataract). They can be unilateral or bilateral and vary in form, size and location, and consequently the visual impact, management course and...

‘The Way Forward’ champions clinicians as architects of patient-centred service redesign

1 April 2017 | | EYE - Cataract, EYE - Glaucoma, EYE - Vitreo-Retinal
The demographic time bomb poses the dilemma of how more healthcare can be delivered to the UK’s ageing population without commensurate growth in resources. The Way Forward Project provides a robust resource for clinical centres to better identify and implement...

Ophthalmic mentors: In conversation with Professor Harminder Dua

1 October 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
In the first of a series of interviews with key figures in the world of ophthalmology, Eye News speaks to Professor Harminder Dua about the future of clinical academia, his recent College presidency and Dua’s Layer. Professor Harminder Dua is...

The role of inflammation in the pathophysiology of DMO

1 February 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup

1 February 2015 | | EYE - Vitreo-Retinal
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...